Effects of dietary supplementation with polyunsaturated ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic arthritis
- PMID: 2139859
- DOI: 10.1177/030006059001800109
Effects of dietary supplementation with polyunsaturated ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic arthritis
Abstract
A total of 80 patients with chronic, stable psoriasis, 34 of whom also had psoriatic arthritis, were treated with 1122 mg/day eicosapentaenoic acid ethyl ester and 756 mg/day docosahexaenoic acid ethyl ester. Before the study and after 4 and 8 weeks of treatment a Psoriatic Association scoring index (PASI) score was assessed. Before treatment the mean PASI score was 3.56, after 4 weeks 1.98 and after 8 weeks 1.24; the decrease in the score was highly significant (P less than 0.001). The degree of pruritus decreased most rapidly, followed by scaling and induration of the plaques, and erythema was most persistent. At the end of the trial, seven patients were completely healed and in 13 other patients more than 75% healing was observed but in 14 patients the result was poor. The majority of patients with psoriatic arthritis reported a subjective improvement in joint pain during the study. It is concluded that polyunsaturated ethyl ester lipids may be useful for the treatment of psoriasis and psoriatic arthritis and may provide an important adjuvant to standard therapy of both conditions.
Similar articles
-
Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis.N Engl J Med. 1993 Jun 24;328(25):1812-6. doi: 10.1056/NEJM199306243282504. N Engl J Med. 1993. PMID: 8502270 Clinical Trial.
-
A low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and in formation of leukotriene B5.Acta Derm Venereol. 1989;69(1):23-8. Acta Derm Venereol. 1989. PMID: 2563604
-
Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects.Arch Dermatol. 1986 Nov;122(11):1277-82. Arch Dermatol. 1986. PMID: 3022655
-
Infliximab in psoriasis and psoriatic arthritis.BioDrugs. 2013 Jan;27 Suppl 1:13-23. doi: 10.1007/BF03325638. BioDrugs. 2013. PMID: 23990278 Review.
-
TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.Postgrad Med J. 2016 Mar;92(1085):172-8. doi: 10.1136/postgradmedj-2015-133419. Epub 2015 Dec 30. Postgrad Med J. 2016. PMID: 26719452 Review.
Cited by
-
Assessment of causal relationships between omega-3 and omega-6 polyunsaturated fatty acids in autoimmune rheumatic diseases: a brief research report from a Mendelian randomization study.Front Nutr. 2024 May 28;11:1356207. doi: 10.3389/fnut.2024.1356207. eCollection 2024. Front Nutr. 2024. PMID: 38863588 Free PMC article.
-
Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise - a review.RMD Open. 2023 Aug;9(3):e003339. doi: 10.1136/rmdopen-2023-003339. RMD Open. 2023. PMID: 37648398 Free PMC article. Review.
-
Oxidative Stress Induced by High Salt Diet-Possible Implications for Development and Clinical Manifestation of Cutaneous Inflammation and Endothelial Dysfunction in Psoriasis vulgaris.Antioxidants (Basel). 2022 Jun 27;11(7):1269. doi: 10.3390/antiox11071269. Antioxidants (Basel). 2022. PMID: 35883760 Free PMC article. Review.
-
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives.Psoriasis (Auckl). 2022 Jun 22;12:151-176. doi: 10.2147/PTT.S328581. eCollection 2022. Psoriasis (Auckl). 2022. PMID: 35769285 Free PMC article. Review.
-
Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.Rheumatol Int. 2021 Jun;41(6):1065-1077. doi: 10.1007/s00296-021-04861-z. Epub 2021 Apr 22. Rheumatol Int. 2021. PMID: 33885930 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical